speb/financial-data huggingface dataset:
Stock screener scorecard for AML.L (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -19.674556213017752%
Revenue growth: -49.182742612176064%
Rule of 40 score: -68.85729882519382
Market cap: 360315488 (Small Cap ($300M-$2B))
Debt to equity: 4.9563
Free cash flow (dilution adjusted): -70000000
Operating income: -74868421.05263157
Net income: -82894736.84210527
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for APA.AX (annual, report date 2025-06-30)
Altman Z-score: 0.8414479029857085 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -7.634112792297114%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.453685703777649%
Free cash flow margin: 10.05656819610308%
Revenue growth: 2.9573545589853043%
Rule of 40 score: 13.013922755088386
Market cap: 13608164352 (Large Cap ($10B-$200B))
P/E ratio: 41.993464052287585
Debt to equity: 4.7706
Free cash flow (dilution adjusted): 209150326.7973856
Operating income: 678431372.5490196
Net income: 84313725.49019608
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for APA.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13608164352 (Large Cap ($10B-$200B))
P/E ratio: 41.993464052287585
Debt to equity: 4.7706
Long score: 0 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for BCHN.SW (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1610159104 (Small Cap ($300M-$2B))
P/E ratio: 17.406087089849738
Debt to equity: 0.42100000000000004
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BIAF (quarterly, report date 2026-03-31)
Altman Z-score: -13.296162628933459 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -226.5263289247034%
Capitalized R&D asset: 1288238.71
ROCI (R&D adjusted): -58.5604863366892%
Rosenberg metric: -0.3226552115464263
Free cash flow margin: -240.26475238748466%
Revenue growth: -12.17080957855178%
Rule of 40 score: -252.43556196603643
Market cap: 4146192 (Nano Cap (< $50M))
Debt to equity: 0.3776
Free cash flow (dilution adjusted): -3247243
Operating income: -3616976
Net income: -3630610
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BPAC11.SA (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.257107835544509%
Capitalized R&D asset: 0
Free cash flow margin: -22.565346022114262%
Revenue growth: 10.893963401811762%
Rule of 40 score: -11.6713826203025
Market cap: 181754068992 (Large Cap ($10B-$200B))
P/E ratio: 17.543476905815623
Debt to equity: 0.9253471480595354
Free cash flow (dilution adjusted): -634136501.9011407
Net income: 902076235.741445
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BPRN (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 278269536 (Micro Cap ($50M-$300M))
P/E ratio: 10.039682539682541
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BSN.DE (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 44960935936 (Large Cap ($10B-$200B))
P/E ratio: 31.001251564455572
Debt to equity: 0.8909
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BUY.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 18710978 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BUY.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 18710978 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CDXS (quarterly, report date 2026-03-31)
Altman Z-score: -5.209731080158204 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -16.33268744941257%
Capitalized R&D asset: 23877510
ROCI (R&D adjusted): -6.460135494248896%
Rosenberg metric: -2.0209879703097005
Free cash flow margin: -96.76023084994753%
Revenue growth: -60.817165617371195%
Rule of 40 score: -157.57739646731872
Market cap: 134526928 (Micro Cap ($50M-$300M))
Debt to equity: 1.6862000000000001
Free cash flow (dilution adjusted): -14754000
Operating income: -8043000
Net income: -8704000
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CORA.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 65050228 (Micro Cap ($50M-$300M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CORA.L (annual, report date 2025-12-31)
Altman Z-score: 244.90561122639173 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.571245642740273%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.381660382727467%
Rule of 40 score: 0
Market cap: 65050228 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -4090540.5405405406
Operating income: -2044594.5945945946
Net income: -1954054.054054054
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for DFSC.V (quarterly, report date 2026-03-31)
Altman Z-score: -7.299612049980607 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -66.92006675529967%
Capitalized R&D asset: 954113.3564564406
ROCI (R&D adjusted): -24.24736952807794%
Rosenberg metric: 0.3267546032998072
Free cash flow margin: -89.91493603572961%
Revenue growth: 59.75699482257505%
Rule of 40 score: -30.157941213154558
Market cap: 5733259 (Nano Cap (< $50M))
Debt to equity: 0.2452
Free cash flow (dilution adjusted): -1371169.784172662
Operating income: -1373158.2733812951
Net income: -1455389.2086330936
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ECOB.L (annual, report date 2025-12-31)
Altman Z-score: -0.3020674920609068 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 87859.45945945947
ROCI (R&D adjusted): -12.527383516349158%
Free cash flow margin: -90.5646744321201%
Revenue growth: 84.03885660282486%
Rule of 40 score: -6.525817829295235
Market cap: 13111826 (Nano Cap (< $50M))
Debt to equity: 0.8863
Free cash flow (dilution adjusted): -2899762.1621621624
Operating income: -2074571.6216216215
Net income: -4131737.837837838
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for ECOB.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13111826 (Nano Cap (< $50M))
Debt to equity: 0.8863
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for EMP.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 76856408 (Micro Cap ($50M-$300M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for EMP.AX (annual, report date 2025-06-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.099190026545735%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -11.546754446501405%
Rule of 40 score: 0
Market cap: 76856408 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1237544.4444444445
Operating income: -661390.8496732026
Net income: -642345.751633987
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for FLOB.BR (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 587253632 (Small Cap ($300M-$2B))
P/E ratio: 95.86056644880175
Debt to equity: 0.6416
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for FMY (quarterly, report date 2025-10-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 48492956 (Nano Cap (< $50M))
P/E ratio: 16.183098591549296
Debt to equity: 0.0005
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FMY (annual, report date 2025-10-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.393534116708002%
Capitalized R&D asset: 0
Revenue growth: -41.77628824601909%
Rule of 40 score: -41.77628824601909
Market cap: 48492956 (Nano Cap (< $50M))
P/E ratio: 16.183098591549296
Debt to equity: 0.0005
Net income: 4553677
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GRD.V (quarterly, report date 2026-03-31)
Altman Z-score: -3.2631338161630015 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.1896845407699597%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.8498604305727766%
Rule of 40 score: 0
Market cap: 4828783 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -39743.165467625906
Operating income: -42182.01438848921
Net income: -46038.12949640288
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for H9W.DE (annual, report date 2025-12-31)
Altman Z-score: 0.7290289718920392 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -24.44306146167606%
Free cash flow margin: -3.471243848540068%
Revenue growth: 28.21265307749337%
Rule of 40 score: 24.7414092289533
Market cap: 35630024 (Nano Cap (< $50M))
Debt to equity: 1.8621
Free cash flow (dilution adjusted): -3078823.529411765
Operating income: -9034384.705882354
Net income: -10661071.764705883
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for H9W.DE (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 35630024 (Nano Cap (< $50M))
Debt to equity: 1.8621
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IPEX (quarterly, report date 2026-03-31)
Altman Z-score: 10.971442958782031 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.2877987919047984%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.6223418055987615%
Rule of 40 score: 0
Market cap: 125405712 (Micro Cap ($50M-$300M))
P/E ratio: 1040
Debt to equity: 0.008378212826186865
Free cash flow (dilution adjusted): -214882
Operating income: -545794
Net income: 240456
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for IPF.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 551998400 (Small Cap ($300M-$2B))
P/E ratio: 0.12725225225225226
Debt to equity: 1.1726999999999999
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IPF.L (annual, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 16.10223642172524%
Capitalized R&D asset: 0
Free cash flow margin: -6.274392074452116%
Revenue growth: 9.80579603845345%
Rule of 40 score: 3.531403964001333
Market cap: 551998400 (Small Cap ($300M-$2B))
P/E ratio: 0.12725225225225226
Debt to equity: 1.1726999999999999
Free cash flow (dilution adjusted): -56486486.48648649
Net income: 73243243.24324325
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for JBDI (quarterly, report date 2025-11-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10180550 (Nano Cap (< $50M))
Debt to equity: 0.2757
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for JKCEMENT.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 3.239375773625841%
Rule of 40 score: 3.239375773625841
Market cap: 436488339456 (Mega Cap (>= $200B))
P/E ratio: 0.4668338738365085
Debt to equity: 0.8752
Operating income: 50743749.34064774
Net income: 29272075.113408584
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KARURVYSYA.NS (annual, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 17.776957116843295%
Capitalized R&D asset: 0
Free cash flow margin: -10.097581188317598%
Revenue growth: 4.548172978602713%
Rule of 40 score: -5.549408209714885
Market cap: 276742995968 (Mega Cap (>= $200B))
P/E ratio: 0.11761890564183831
Debt to equity: 0.1858934055956002
Free cash flow (dilution adjusted): -75152607.03688003
Net income: 266037515.89656633
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for KARURVYSYA.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: -6.000708706316339%
Rule of 40 score: -6.000708706316339
Market cap: 327587168256 (Mega Cap (>= $200B))
P/E ratio: 0.10914044240121604
Net income: 79723599.53581601
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KCPSUGIND.NS (annual, report date 2026-03-31)
Altman Z-score: 1.7268761129386954 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.5902164870327127%
Capitalized R&D asset: 10058.386675363301
ROCI (R&D adjusted): -0.9695760179161473%
Rosenberg metric: -274.53629411681806
Free cash flow margin: -19.338174472566987%
Revenue growth: -24.096286642680287%
Rule of 40 score: -43.434461115247274
Market cap: 3182769408 (Mid Cap ($2B-$10B))
P/E ratio: 0.25041880014297346
Debt to equity: 0.2779
Free cash flow (dilution adjusted): -5327359.7181008905
Operating income: -539442.9313268334
Net income: 1179603.518440017
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for KCPSUGIND.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.4267566087186965 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.8071427021703137%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.3475368297470656%
Revenue growth: 1.3477619822862414%
Rule of 40 score: 1.3477619822862414
Market cap: 3182769408 (Mid Cap ($2B-$10B))
P/E ratio: 0.25041880014297346
Debt to equity: 0.2779
Operating income: -759601.5260703688
Net income: -1610428.1475201356
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for KME.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 25195588 (Nano Cap (< $50M))
P/E ratio: 6.100217864923748
Debt to equity: 0.1249
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KME.AX (annual, report date 2025-06-30)
Altman Z-score: 2.6506482729395655 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -67.29986431478969%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.772362569345743%
Free cash flow margin: 13.742774104947141%
Revenue growth: -4.714865832103884%
Rule of 40 score: 9.027908272843257
Market cap: 25195588 (Nano Cap (< $50M))
P/E ratio: 6.100217864923748
Debt to equity: 0.1249
Free cash flow (dilution adjusted): 2812418.3006535945
Operating income: 2105882.3529411764
Net income: -3474509.8039215687
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for LARK (quarterly, report date 2026-03-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.3550751486057635%
Capitalized R&D asset: 0
Free cash flow margin: 35.27971469633257%
Revenue growth: 0.5297517123287672%
Rule of 40 score: 35.809466408661336
Market cap: 192316800 (Micro Cap ($50M-$300M))
P/E ratio: 7.862619808306709
Debt to equity: 0.5489292189269295
Free cash flow (dilution adjusted): 6628000
Net income: 5066000
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for LENZ (quarterly, report date 2026-03-31)
Altman Z-score: 3.1192293364986887 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -16.79364847540691%
Capitalized R&D asset: 1251030
ROCI (R&D adjusted): -18.30738816616268%
Free cash flow margin: -1994.687006838506%
Revenue growth: 19.710327455919398%
Rule of 40 score: -1974.9766793825866
Market cap: 171822080 (Micro Cap ($50M-$300M))
Debt to equity: 0.0027
Free cash flow (dilution adjusted): -37919000
Operating income: -44135000
Net income: -41488000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for LRV.AX (annual, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -60.59136748603431%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.090161839157732%
Rule of 40 score: 0
Market cap: 586855168 (Small Cap ($300M-$2B))
Debt to equity: 1.4601
Free cash flow (dilution adjusted): -43496934.22818792
Operating income: -13573738.255033556
Net income: -12826891.275167786
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for LRV.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 586855168 (Small Cap ($300M-$2B))
Debt to equity: 1.4601
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for LSPD.TO (quarterly, report date 2026-03-31)
Altman Z-score: 4.313465291438293 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 44152713.910623334
ROCI (R&D adjusted): -2.3954865908116267%
Rosenberg metric: -0.19059578333897953
Free cash flow margin: -13.476504066438558%
Revenue growth: -8.239292553586225%
Rule of 40 score: -21.715796620024783
Market cap: 1833120384 (Small Cap ($300M-$2B))
Debt to equity: 0.013600000000000001
Free cash flow (dilution adjusted): -28193525.179856118
Operating income: -24434532.374100722
Net income: -20551798.56115108
Long score: 4 | Short score: 12
Recommendation: Short
Stock screener scorecard for LSPD.TO (annual, report date 2026-03-31)
Altman Z-score: 4.650536504766006 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.034738247306546004%
Capitalized R&D asset: 178900648.5742874
ROCI (R&D adjusted): -8.392828143698697%
Rosenberg metric: 0.7635369844316513
Free cash flow margin: -4.966724963856286%
Revenue growth: 17.229401617252275%
Rule of 40 score: 12.262676653395989
Market cap: 1833120384 (Small Cap ($300M-$2B))
Debt to equity: 0.013600000000000001
Free cash flow (dilution adjusted): -43844604.31654676
Operating income: -106176978.41726619
Net income: -103893525.17985612
Long score: 5 | Short score: 10
Recommendation: Neutral
Stock screener scorecard for MEX.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 9789883 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MLPHO.PA (annual, report date 2021-12-31)
Altman Z-score: 0.41159538755213076 (Distress Zone)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.6743482476145104%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.04518929166492282%
Rule of 40 score: 0
Market cap: 12166844 (Nano Cap (< $50M))
Debt to equity: 0.2726359030048766
Operating income: -43581.818181818184
Net income: -511034.0909090909
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for ONEX.TO (quarterly, report date 2026-03-31)
Altman Z-score: 8.395873044738652 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.4145926398638586%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.2884538553735516%
Free cash flow margin: -437.9679144385027%
Revenue growth: -20.89727359743106%
Rule of 40 score: -458.8651880359338
Market cap: 8135190016 (Mid Cap ($2B-$10B))
P/E ratio: 6.246724985050521
Debt to equity: 0.0031
Free cash flow (dilution adjusted): -589208633.0935252
Operating income: 92805755.39568345
Net income: 92805755.39568345
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for PAM.L (annual, report date 2026-03-31)
Altman Z-score: 3.5775805146300668 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 17.709265890778873%
Capitalized R&D asset: -393401.2303485988
ROCI (R&D adjusted): 9.475946730071591%
Free cash flow margin: 2.0167505431855743%
Revenue growth: 0.9091471048056212%
Rule of 40 score: 2.925897647991196
Market cap: 16446556 (Nano Cap (< $50M))
P/E ratio: 0.10087719298245615
Debt to equity: 0.11810000000000001
Free cash flow (dilution adjusted): 1428947.3684210526
Operating income: 3825000
Net income: 2752631.5789473685
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for PAM.L (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 16446556 (Nano Cap (< $50M))
P/E ratio: 0.10087719298245615
Debt to equity: 0.11810000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PAR.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.653958607395336 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.5904865490433504%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.4454886908746699%
Revenue growth: -36.4104289869714%
Rule of 40 score: -36.4104289869714
Market cap: 1154051840 (Small Cap ($300M-$2B))
P/E ratio: 0.07784768681017666
Debt to equity: 0
Operating income: 54514.62484103434
Net income: 90462.06019499789
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for PAR.NS (annual, report date 2026-03-31)
Altman Z-score: 5.634208475248474 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.281826251109527%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.629298675745028%
Free cash flow margin: 13.960171954047828%
Revenue growth: -6.939223219818571%
Rule of 40 score: 7.020948734229258
Market cap: 1154051840 (Small Cap ($300M-$2B))
P/E ratio: 0.07784768681017666
Debt to equity: 0
Free cash flow (dilution adjusted): 1533541.754980924
Operating income: 1423081.8143281052
Net income: 1389211.5303094531
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for PEHN.SW (annual, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.6711053882311067%
Capitalized R&D asset: 0
Revenue growth: -238.3824221323045%
Rule of 40 score: -238.3824221323045
Market cap: 150834224 (Micro Cap ($50M-$300M))
Debt to equity: 0.0416
Free cash flow (dilution adjusted): -647500
Net income: -17533750
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for PEHN.SW (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 150834224 (Micro Cap ($50M-$300M))
Debt to equity: 0.0416
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RAPP (quarterly, report date 2026-03-31)
Altman Z-score: 45.03978523557471 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.181441829688322%
Capitalized R&D asset: 60340930
ROCI (R&D adjusted): -3.6879920687986867%
Free cash flow margin: -100.55000000000001%
Rule of 40 score: -100.55000000000001
Market cap: 1945599488 (Small Cap ($300M-$2B))
Debt to equity: 0.0229
Free cash flow (dilution adjusted): -20110000
Operating income: -24215000
Net income: -19857000
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for SEQUA.BR (quarterly, report date 2025-06-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 47763112 (Nano Cap (< $50M))
Debt to equity: -1.0568624225601657
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SILLYMONKS.NS (annual, report date 2026-03-31)
Altman Z-score: 5.442845160785124 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.219331635954191%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.63734898949983%
Free cash flow margin: -14.52972935497569%
Revenue growth: -20.279849284560267%
Rule of 40 score: -34.80957863953596
Market cap: 161236432 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -355362.4417125901
Operating income: -205489.61424332345
Net income: -210565.91776176347
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for SILLYMONKS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.405056070274135 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.808725537153277%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.698527395603154%
Revenue growth: -14.471507007451029%
Rule of 40 score: -14.471507007451029
Market cap: 161236432 (Micro Cap ($50M-$300M))
Debt to equity: 0
Operating income: -114306.90970750318
Net income: -118524.798643493
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for SOCA (quarterly, report date 2026-03-31)
Altman Z-score: 18.752284215233438 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.8102928285999461%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.11077471843267106%
Rule of 40 score: 0
Market cap: 241535008 (Micro Cap ($50M-$300M))
P/E ratio: 51.80225420627662
Debt to equity: 0
Free cash flow (dilution adjusted): -132039
Operating income: -197685
Net income: 1386466
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for UG (quarterly, report date 2026-03-31)
Altman Z-score: 14.209937443832871 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.686647648109111%
Capitalized R&D asset: 236931.58000000002
ROCI (R&D adjusted): 5.568291678132989%
Rosenberg metric: 0.7385377942998761
Free cash flow margin: 20.703483226575102%
Revenue growth: -3.0262453766305235%
Rule of 40 score: 17.67723784994458
Market cap: 35008712 (Nano Cap (< $50M))
P/E ratio: 12.884615384615385
Debt to equity: 0
Free cash flow (dilution adjusted): 594650
Operating income: 642449
Net income: 818902
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for UONEK (quarterly, report date 2026-03-31)
Altman Z-score: -2.12349446329115 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.45041197953523177%
Free cash flow margin: 23.849016754452617%
Revenue growth: -20.62497444494419%
Rule of 40 score: 3.2240423095084267
Market cap: 22948620 (Nano Cap (< $50M))
Debt to equity: 20.1936
Free cash flow (dilution adjusted): 18519000
Operating income: -2215000
Net income: -3079000
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for XMAX (quarterly, report date 2026-03-31)
Altman Z-score: 46.267945724191044 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.8773472212815177%
Capitalized R&D asset: -702.1800000000001
ROCI (R&D adjusted): -1.1717798257681906%
Free cash flow margin: -36.01820936050032%
Revenue growth: 0.6809175264780855%
Rule of 40 score: -35.33729183402224
Market cap: 536167648 (Small Cap ($300M-$2B))
P/E ratio: 601.105976899861
Debt to equity: 0.1515
Free cash flow (dilution adjusted): -641744
Operating income: -534853
Net income: 191514
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for YNGA.L (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 546559936 (Small Cap ($300M-$2B))
P/E ratio: 0.21754385964912282
Debt to equity: 0.3972
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7674.T (annual, report date 2026-01-31)
Altman Z-score: 3.742081512246166 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -66.64527998811737%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -28.398178532282625%
Free cash flow margin: -2.174953107161394%
Revenue growth: 7.422695067845865%
Rule of 40 score: 5.247741960684471
Market cap: 7074485152 (Mid Cap ($2B-$10B))
Debt to equity: 0.4555743954480796
Free cash flow (dilution adjusted): -1091094.2804909898
Operating income: -3285107.0775659443
Net income: -6072910.681640115
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for AIRE.L (annual, report date 2024-06-30)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.6194161637566986%
Capitalized R&D asset: 0
Free cash flow margin: 126.83695994954272%
Rule of 40 score: 126.83695994954272
Market cap: 450800.0000000001 (Nano Cap (< $50M))
P/E ratio: 0.19126007636826478
Debt to equity: 0.6269559742632945
Free cash flow (dilution adjusted): 5091139.240506329
Net income: 2983544.303797468
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AMG (annual, report date 2025-12-31)
Altman Z-score: 2.5551306844520725 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -114.64435146443515%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.657996547824534%
Free cash flow margin: 36.84438873891246%
Revenue growth: 1.6414327012592482%
Rule of 40 score: 38.485821440171705
Market cap: 7613547622.099999 (Mid Cap ($2B-$10B))
P/E ratio: 8.422065953650442
Debt to equity: 0.6086022478008186
Free cash flow (dilution adjusted): 764300000
Operating income: 475300000
Net income: 904000000
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for AML.L (annual, report date 2025-12-31)
Altman Z-score: -0.8544160744476288 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.055212373701096%
Free cash flow margin: -21.221276934086028%
Revenue growth: -14.156469747100461%
Rule of 40 score: -35.37774668118649
Market cap: 6481223.0016 (Nano Cap (< $50M))
Debt to equity: 4.835965978128797
Free cash flow (dilution adjusted): -360675675.6756757
Operating income: -255540540.54054055
Net income: -666216216.2162162
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BIAF (annual, report date 2025-12-31)
Altman Z-score: -9.680533057181474 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -280.53655637965045%
Capitalized R&D asset: 3852750.95
ROCI (R&D adjusted): -87.36558731728735%
Rosenberg metric: -0.8398688191366562
Free cash flow margin: -164.717608615251%
Revenue growth: -34.75812169636004%
Rule of 40 score: -199.47573031161104
Market cap: 7414011.9799999995 (Nano Cap (< $50M))
Debt to equity: 0.15950479110306945
Free cash flow (dilution adjusted): -10060884
Operating income: -10626508
Net income: -14909754
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for BPAC11.SA (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 27.93535174137593%
Capitalized R&D asset: 0
Free cash flow margin: -51.058044802833315%
Revenue growth: 55.10864484728899%
Rule of 40 score: 4.050600044455678
Market cap: 172887967632.2137 (Large Cap ($10B-$200B))
P/E ratio: 10.315323476047347
Debt to equity: 0.9198995903739942
Free cash flow (dilution adjusted): -4841839233.576642
Net income: 3058449817.518248
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for BPRN (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.03415432549151%
Capitalized R&D asset: 0
Free cash flow margin: 22.8836182860126%
Revenue growth: 12.848286850455903%
Rule of 40 score: 35.7319051364685
Market cap: 231783434.5 (Micro Cap ($50M-$300M))
P/E ratio: 12.454109639460535
Debt to equity: 0.07828984308046928
Free cash flow (dilution adjusted): 19287000
Net income: 18611000
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for CDXS (annual, report date 2025-12-31)
Altman Z-score: -4.632872285887613 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -89.85977614113926%
Capitalized R&D asset: 102735260
ROCI (R&D adjusted): -17.099196564211503%
Rosenberg metric: 0.38890690184380605
Free cash flow margin: -47.55281515052496%
Revenue growth: 18.60645378717668%
Rule of 40 score: -28.946361363348277
Market cap: 148161404.20999998 (Micro Cap ($50M-$300M))
Debt to equity: 1.448831364167112
Free cash flow (dilution adjusted): -33471000
Operating income: -38332000
Net income: -43974000
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for GRD.V (annual, report date 2025-12-31)
Altman Z-score: 4.105842842420509 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.43804271332661%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -14.189249485400158%
Rule of 40 score: 0
Market cap: 6438378.160000001 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -171495.62043795618
Operating income: -210070.80291970802
Net income: -220834.30656934305
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for IPEX (annual, report date 2025-12-31)
Altman Z-score: 10.608421963109071 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.47638217654242937%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.1140293566842896%
Rule of 40 score: 0
Market cap: 112251175 (Micro Cap ($50M-$300M))
P/E ratio: 282.83974430042935
Debt to equity: 0.006001710583543679
Free cash flow (dilution adjusted): -701278
Operating income: -2717289
Net income: 396872
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for JBDI (annual, report date 2025-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 56950182.739199996 (Micro Cap ($50M-$300M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KRO (annual, report date 2025-12-31)
Altman Z-score: 1.3766185330306813 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.890447561790248%
Capitalized R&D asset: 31320000
ROCI (R&D adjusted): -2.8323824459886975%
Rosenberg metric: -10.45
Free cash flow margin: -2.1727438958803917%
Revenue growth: -1.4678607386995919%
Rule of 40 score: -3.640604634579984
Market cap: 500481054.59999996 (Small Cap ($300M-$2B))
Debt to equity: 0.7686060444681134
Free cash flow (dilution adjusted): -40400000
Operating income: -41900000
Net income: -110900000
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for LARK (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 16.903514117408083%
Capitalized R&D asset: 0
Free cash flow margin: 29.26269890707288%
Revenue growth: 16.815505722034796%
Rule of 40 score: 46.078204629107674
Market cap: 157255866.07999998 (Micro Cap ($50M-$300M))
P/E ratio: 8.375811775233023
Debt to equity: 0.20057149616201106
Free cash flow (dilution adjusted): 20670000
Net income: 18775000
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for LENZ (annual, report date 2025-12-31)
Altman Z-score: 13.11493343117749 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -29.073394785801455%
Capitalized R&D asset: 58272990
ROCI (R&D adjusted): -31.62439857159292%
Rosenberg metric: 0.6264890439918124
Free cash flow margin: -432.4392288348701%
Rule of 40 score: -432.4392288348701
Market cap: 501670304 (Small Cap ($300M-$2B))
Debt to equity: 0.0028662969202255056
Free cash flow (dilution adjusted): -82544000
Operating income: -91138000
Net income: -82127000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for ONEX.TO (annual, report date 2025-12-31)
Altman Z-score: 3.5919299277534273 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.006369426751593%
Capitalized R&D asset: 5563906.896023684
ROCI (R&D adjusted): 5.549604792509951%
Rosenberg metric: 75.4361313868613
Free cash flow margin: 73.24414715719062%
Revenue growth: 44.71169575469035%
Rule of 40 score: 117.95584291188098
Market cap: 8582407422.6 (Mid Cap ($2B-$10B))
P/E ratio: 13.909898577957861
Debt to equity: 0.27034718269778035
Free cash flow (dilution adjusted): 479562043.7956204
Operating income: 454014598.54014593
Net income: 450364963.5036496
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for RAPP (annual, report date 2025-12-31)
Altman Z-score: 31.01746665336488 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -22.919903518599906%
Capitalized R&D asset: 144855120
ROCI (R&D adjusted): -14.344355276609422%
Rule of 40 score: 0
Market cap: 1451069025.86 (Small Cap ($300M-$2B))
Debt to equity: 0.02369530365024048
Free cash flow (dilution adjusted): -106944000
Operating income: -125099000
Net income: -111483000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for SAUD3.SA (annual, report date 2025-12-31)
Altman Z-score: 7.854153788993587 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 265.2029957349062%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 55.00267205459565%
Free cash flow margin: 20.869992426117456%
Revenue growth: 19.643738791395837%
Rule of 40 score: 40.513731217513296
Market cap: 5974221318.56 (Mid Cap ($2B-$10B))
P/E ratio: 10.254941583946994
Debt to equity: 0.01623871899576056
Free cash flow (dilution adjusted): 92169160.5839416
Operating income: 140484854.01459852
Net income: 106308394.16058393
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for SEQUA.BR (annual, report date 2024-12-31)
Altman Z-score: -44.33507760654719 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -19122.337440758296%
Revenue growth: -86.11204721324734%
Rule of 40 score: -19208.449487971542
Market cap: 239206420.98 (Micro Cap ($50M-$300M))
Debt to equity: -0.903839779993374
Free cash flow (dilution adjusted): -21014652.083333336
Operating income: -18982320.833333336
Net income: -46514184.375
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for VIK (annual, report date 2025-12-31)
Altman Z-score: 1.5685043413511421 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 24.090528922339445%
Earnings yield: 3.2131597984512412%
Return on net tangible assets: 40.31953272633568%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 23.04577341030739%
Free cash flow margin: 22.224963504121177%
Revenue growth: 21.889066912241404%
Rule of 40 score: 44.11403041636258
Market cap: 22735944260 (Large Cap ($10B-$200B))
P/E ratio: 19.803190728990195
Debt to equity: 5.11966554360757
Free cash flow (dilution adjusted): 1444938000
Operating income: 1501534000
Net income: 1148095000
Long score: 8 | Short score: 4
Recommendation: Long
Stock screener scorecard for 1780.T (annual, report date 2026-03-31)
Altman Z-score: 4.685749106906306 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 18.735301494926663%
Earnings yield: 0.09724179167656975%
Return on net tangible assets: 9.987229256367625%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.214020116493643%
Free cash flow margin: -6.307561073588356%
Revenue growth: 6.518616765200587%
Rule of 40 score: 0.21105569161223148
Market cap: 28592723968 (Large Cap ($10B-$200B))
P/E ratio: 0.057113227129977545
Debt to equity: 0
Free cash flow (dilution adjusted): -15992461.21121121
Operating income: 26645708.208208207
Net income: 19801107.357357357
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 1931.HK (annual, report date 2025-12-31)
Altman Z-score: 1.2635493269901765 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 18.377642407977245%
Earnings yield: 1.138309690415859%
Return on net tangible assets: 1.425505883070402%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.264104740899376%
Free cash flow margin: -35.812076806055885%
Revenue growth: -6.984106856852848%
Rule of 40 score: -42.79618366290873
Market cap: 992978432 (Small Cap ($300M-$2B))
P/E ratio: 16.966580976863753
Debt to equity: 0.64
Free cash flow (dilution adjusted): -144305428.57142857
Operating income: 29367000
Net income: 5343714.285714285
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for 4188.T (annual, report date 2026-03-31)
Altman Z-score: 1.389220217814826 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 1.1584836272329109%
Earnings yield: 0.005569892399335853%
Return on net tangible assets: 14.895727473543928%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7224108453902712%
Free cash flow margin: 3.891859260883135%
Revenue growth: -12.169703117378212%
Rule of 40 score: -8.277843856495078
Market cap: 1615312977920 (Mega Cap (>= $200B))
P/E ratio: 15.573275642550207
Debt to equity: 0.7829
Free cash flow (dilution adjusted): 901864364.3643644
Operating income: 202283533.53353354
Net income: 490646896.8968969
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6788.T (annual, report date 2026-03-31)
Altman Z-score: 4.3493537869463585 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 14.23320693907664%
Earnings yield: 0.08270542049687354%
Return on net tangible assets: 10.147107193791957%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.375815750978191%
Free cash flow margin: 8.702063046943746%
Revenue growth: 0.6713412821381596%
Rule of 40 score: 9.373404329081906
Market cap: 33639710720 (Large Cap ($10B-$200B))
P/E ratio: 0.09905526424492644
Debt to equity: 0.0421
Free cash flow (dilution adjusted): 13152921.671671672
Operating income: 18396753.003003
Net income: 14221327.577577578
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 6Z1.DE (quarterly, report date 2026-03-31)
Altman Z-score: 2.4196861687369986 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.1883377089954401%
Earnings yield: 0.13286165263186203%
Return on net tangible assets: 2.329305575775222%
Capitalized R&D asset: 1226340000
ROCI (R&D adjusted): 1.0207858225965487%
Rosenberg metric: -0.3293718166383701
Free cash flow margin: 48.46900672143391%
Revenue growth: -3.599712023038157%
Rule of 40 score: 44.86929469839575
Market cap: 74199982080 (Large Cap ($10B-$200B))
P/E ratio: 34.88424801683665
Debt to equity: 0.3319
Free cash flow (dilution adjusted): 1298000000
Operating income: 86000000
Net income: 160000000
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 7084.T (annual, report date 2026-03-31)
Altman Z-score: 1.9282452247176936 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.053177836895412%
Earnings yield: 0.023856741075172463%
Return on net tangible assets: -1.0670989791457264%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.920689623758962%
Free cash flow margin: -3.108259289519675%
Revenue growth: -0.4944232914128207%
Rule of 40 score: -3.6026825809324956
Market cap: 8837348352 (Mid Cap ($2B-$10B))
P/E ratio: 0.2714064071384533
Debt to equity: 1.0717
Free cash flow (dilution adjusted): -2823023.023023023
Operating income: 2315590.5905905906
Net income: 1380536.7867867867
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 8041.T (annual, report date 2026-03-31)
Altman Z-score: 4.942699295609083 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 16.55604912464071%
Earnings yield: 0.08786972502613939%
Return on net tangible assets: 12.570403859268053%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.2118572199522%
Free cash flow margin: 0.33382279344233445%
Revenue growth: -2.764535655818509%
Rule of 40 score: -2.4307128623761742
Market cap: 24181190656 (Large Cap ($10B-$200B))
P/E ratio: 0.02535641580585401
Debt to equity: 0.5384
Free cash flow (dilution adjusted): 7595095.095095095
Operating income: 39639639.63963964
Net income: 33652402.4024024
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 9858.HK (annual, report date 2025-12-31)
Altman Z-score: 0.604337632782241 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 12.36147285983524%
Earnings yield: 0.268388007721585%
Return on net tangible assets: -4.59936753628402%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.276885277313859%
Free cash flow margin: 2.7468774853287825%
Revenue growth: 7.179007474917748%
Rule of 40 score: 9.925884960246531
Market cap: 16617542656 (Large Cap ($10B-$200B))
Debt to equity: 2.1666
Free cash flow (dilution adjusted): 81047428.57142857
Operating income: 103219428.57142857
Net income: -61769428.571428575
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for AIL.DE (annual, report date 2025-12-31)
Altman Z-score: 4.151927537379829 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 19.795026945258577%
Earnings yield: 5.020032705452751%
Return on net tangible assets: 23.262901259650555%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.151144705013857%
Free cash flow margin: 9.929399187830825%
Revenue growth: 12.450305728955827%
Rule of 40 score: 22.37970491678665
Market cap: 112269017088 (Large Cap ($10B-$200B))
P/E ratio: 33.50707371556218
Debt to equity: 0.5065999999999999
Free cash flow (dilution adjusted): 3147058823.529412
Operating income: 6158000000
Net income: 4287529411.764706
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)